Enveric Biosciences Announces It Will Build On Its Recent Business Development Momentum By Soliciting Requests-For-Proposal For License Or Sale Of Its Psyai Trademark Portfolio As A Means Of Maximizing Value For An Asset Which Is No Longer Strategic Given